Afoxolaner

Afoxolaner is an inhibitor of GABA Receptors and Glutamate Receptors used in studies of Calcium Signaling and Neurotransmission. In practice, this places the compound in experiments that measure calcium flux, excitability, and secretion-linked signaling and synaptic signaling, receptor activity, and neuronal excitability in neuroscience models.

By inhibiting GABA Receptors and Glutamate Receptors, Afoxolaner can be used to examine calcium flux, excitability, and secretion-linked signaling and synaptic signaling, receptor activity, and neuronal excitability. This context is compatible with calcium-mobilization, membrane-activity, and signaling assays and electrophysiology, neurotransmission, and receptor-response assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving GABA Receptors and Glutamate Receptors
• Pathway perturbation studies connected to Calcium Signaling and Neurotransmission
• Concentration-response inhibition and target-dependence studies
• Phenotypic profiling in neuroscience models

Overall, Afoxolaner is appropriate when a defined chemical perturbant is needed to connect GABA Receptors and Glutamate Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.